Germany GLP-1 Drugs Market Trends The use of GLP-1 drugs in Germany is increasing due to growing incidences of type 2 diabetes as well as obesity
Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke D : Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome
However, the lack of FDA approval and oversight for the final compounded products introduces inherent risks. Douglas Ewing, MD, FACS, DABOM Concerns have been raised about the potential for contamination, impurities, and incorrect dosages in some compounded products, Ewing continued
Metabolic reprogramming and cancer progression
Vision loss: NAION A 2024 study published in JAMA Ophthalmology found a significantly elevated risk of non-arteritic anterior ischemic optic neuropathy (NAION), a form of vision loss caused by reduced blood flow to the optic nerve, in people taking semaglutide
Photoluminescence spectrum of Na-amox Figure 2